» Authors » N N Zein

N N Zein

Explore the profile of N N Zein including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 55
Citations 837
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kwon J, Hanouneh I, Allende D, Yerian L, Diago T, Eghtesad B, et al.
Transplant Proc . 2018 Jun; 50(5):1451-1456. PMID: 29880369
Introduction: De novo autoimmune hepatitis, also known as plasma cell hepatitis, is an increasingly recognized entity following liver transplantation. The aim of this study is to investigate the long-term outcomes...
2.
Rifai G, Anani A, Hanouneh I, Mohamad B, Matloob A, Lopez R, et al.
Transplant Proc . 2016 Dec; 48(10):3362-3367. PMID: 27931582
Background: Chronic hepatitis B virus (HBV) infection has a mild course in most children that may delay initiation of treatment even when indicated. Unfortunately, a small number of cases can...
3.
Issa D, Eghtesad B, Zein N, Yerian L, Cruise M, Alkhouri N, et al.
Int J Organ Transplant Med . 2016 Feb; 7(1):38-45. PMID: 26889372
Fibrosing cholestatic hepatitis (FCH) is an aggressive form of hepatitis C virus (HCV) recurrence after orthotopic liver transplantation (OLT), which frequently results in graft failure and death. Treatment of FCH...
4.
Ascha M, Ascha M, Zein N, Alkhouri N, Eghtesad B, Abu-Elmagd K, et al.
Int J Organ Transplant Med . 2015 Jun; 6(2):86-90. PMID: 26082832
Hepatitis C virus (HCV) infection remains a leading indication for orthotopic liver transplantation (OLT) worldwide. Recurrence of HCV following OLT is universal. There is scarcity of data on the post-OLT...
5.
Confer B, Choudhary M, Lopez R, Zein N
Transplant Proc . 2015 Feb; 47(1):217-22. PMID: 25645807
Background: After liver transplant (LT), the risk of hepatocellular carcinoma (HCC) recurrence is partially dependent on the degree of immunosuppression. We aimed to determine whether assessing net state of CD4(+)...
6.
Modaresi Esfeh J, Hanouneh I, Dalal D, Tabba A, Lopez R, Pagadala M, et al.
Int J Organ Transplant Med . 2014 Jul; 3(4):157-63. PMID: 25013641
Background: Liver transplantation (LT) increases the risk of de novo malignancies including skin cancers. However, risk factors for this type of cancers have not been well studied. Objective: To determine...
7.
Sourianarayanane A, Aucejo F, Miller C, Lopez R, Zein N, McCullough A, et al.
Int J Organ Transplant Med . 2014 Jul; 3(2):85-91. PMID: 25013628
Background: There is increased prevalence of hepatocellular carcinoma (HCC) among African Americans (AA). Multicenter studies have shown advanced presentation, underutilization of treatment and decreased survival following liver transplantation (LT) among...
8.
Hanouneh I, Macaron C, Lopez R, Feldstein A, Yerian L, Eghtesad B, et al.
Int J Organ Transplant Med . 2014 Jul; 2(2):57-65. PMID: 25013596
Background: Nonalcoholic steatohepatitis (NASH) is an increasing indication for orthotopic liver transplantation (OLT) in the United States and other countries. However, the incidence of disease recurrence and natural course following...
9.
Hanouneh I, Zein N, Lopez R, Yerian L, Fung J, Eghtesad B
Int J Organ Transplant Med . 2014 Jul; 1(1):7-14. PMID: 25013557
Background: Recurrence of hepatitis C virus (HCV) infection following orthotopic liver transplantation (OLT) is universal. There is paucity of data on the safety and efficacy of interleukin (IL)-2 receptor antagonist...
10.
John B, Konjeti R, Aggarwal A, Lopez R, Atreja A, Miller C, et al.
Ann Hepatol . 2013 Oct; 12(6):952-8. PMID: 24114826
Background And Aims: Most portal vein thromboses (PVT) in cirrhotics are discovered incidentally. While case series demonstrate improved portal vein patency with anti-coagulation, there is little information on impact of...